ARCHIVES

ODAC Votes 13:0 to Recommend Perjeta for Accelerated Approval

This article is from The Cancer Letter archive.

Vol. 39 No. 34 | September 13, 2013

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

In Brief: EORTC-NCI Exchange Program Invites U.S. applicants; USC Seeks Eye Melanoma Patients

December 5, 1986

Bush Nominates Health Policy Advisor McClellan For FDA Commissioner

September 27, 2002

Building Boom of Proton Beam Centers Flares Up in Washington and Baltimore

October 25, 2013

Phase III Avastin Trial Fails Primary Endpoints

February 28, 2014

UCSD Cancer Center Breaks Ground for New Building

November 15, 2002